Noonan syndrome: rhGH treatment and PTPN11 mutation

OBJECTIVE: To analyze the clinical data and genetic characteristics of Noonan syndrome, both the effect and side effects of recombinant human growth hormone (rhGH) treatment. METHODS: We collected clinical data from 8 children with Noonan syndrome diagnosed from November 2017 to June 2021. The diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xian, Wu, Jiali, Yuan, Yi, Yang, Li, Yu, Lirong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Clinical Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655517/
https://www.ncbi.nlm.nih.gov/pubmed/37525886
http://dx.doi.org/10.1002/mgg3.2266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655517/
https://www.ncbi.nlm.nih.gov/pubmed/37525886
http://dx.doi.org/10.1002/mgg3.2266

Ejemplares similares